Iranian Scientists Produce Radiopharmaceutical Used for 90 Percent of Cancer Patients

The radiopharmaceutical produced by the company, as one of the most specialized radiopharmaceuticals for lymph node diagnosis, has settled this problem. By injecting this radiopharmaceutical and performing a scan, surgeons can identify the exact location and extent of cancer-infected lymph nodes. This technology increases the accuracy of diagnosis and prevents unnecessary surgeries and its complications.
The production of this advanced radiopharmaceutical was monopolized by the US since 2013 but with the efforts of the Iranian specialists, the technical know-how for its production became completely indigenous. After successfully passing the preclinical stages, this medicine has entered the clinical phase.
This product is a complex polymer macromolecule that, in addition to being able to carry the technetium diagnostic radioisotope, can bind to receptors on the surface of cancer cells. This feature allows this drug to identify cancer cells with high accuracy.
Radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. They may be given to the patient in several different ways. For example, they may be given by mouth, given by injection, or placed into the eye or into the bladder.
4155/v